Quaternity method for integrated screening, separation, extraction optimization, and bioactivity evaluation of acetylcholinesterase inhibitors from Sophora flavescens Aiton
Phytochemical Analysis · 2025-01 · 36 (1) · 52-67
DOI: 10.1002/pca.3415 ↗At a glance
Journal article in Phytochemical Analysis, published online on 2024-07-03. Written by Yutong Zhang and 7 co-authors. Institution: Central Laboratory, Changchun Normal University, Changchun, China. Major MEDLINE topics: Sophora, Cholinesterase Inhibitors. Cited 7 times so far (Crossref); 42 references. Funded by: Natural Science Foundation of China, Natural Science Foundation of Changchun Normal University, Natural Science Foundation of Jilin Province.
Abstract (original language)
Introduction
Sophora flavescens Aiton (Fabaceae), a ubiquitous plant species in Asia, contains a wide range of pharmacologically active compounds, such as flavonoids, with potential anti‐Alzheimer's disease (anti‐AD) effects.
Objectives
The objective of the study is to develop a quaternity method for the screening, isolation, extraction optimization, and activity evaluation of acetylcholinesterase (AChE)‐inhibiting compounds from S. flavescens to realize high‐throughput screening of active substances in traditional Chinese medicine and to provide experimental data for the development of anti‐AD drugs.
Methods
With AChE as the target molecule, affinity ultrafiltration and liquid chromatography‐mass spectrometry were applied to screen for potential inhibitors of the enzyme in S. flavescens . Orthogonal array experiments combined with the multi‐objective Non‐Dominated Sorting Genetic Algorithm III was used for the first time to optimize the process for extracting the active substances. Enzyme inhibition kinetics and molecular docking studies were performed to verify the potential anti‐AD effects of the active compounds.
Results
Five AChE‐inhibiting compounds were identified: kushenol I, kurarinone, sophoraflavanone G, isokurarinone, and kushenol E. These were successfully separated at purities of 72.88%, 98.55%, 96.86%, 96.74%, and 95.84%, respectively, using the n ‐hexane/ethyl acetate/methanol/water (4.0/5.0/4.0/5.0, v/v/v/v), n ‐hexane/ethyl acetate/methanol/water (5.0/5.0/6.0/4.0, v/v/v/v), and n ‐hexane/ethyl acetate/methanol/water (4.9/5.1/5.7/4.3, v/v/v/v) mobile phase systems. Enzyme inhibition kinetics revealed that kushenol E had the best inhibitory effect.
Conclusion
This study elucidates the mechanism of action of five active AChE inhibitors in S. flavescens and provides a theoretical basis for the screening and development of anti‐AD and other therapeutic drugs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Central Laboratory, Changchun Normal University, Changchun, China.
ORCID profiles: Yuchi Zhang
Funding
- Natural Science Foundation of China
- Natural Science Foundation of Changchun Normal University
- Natural Science Foundation of Jilin Province
- National Natural Science Foundation of China
Cite
APA
Zhang, Y., Zhang, Y., Li, S., Liu, C., Liang, J., Nong, Y., Chen, M., & Sun, R. (2025). Quaternity method for integrated screening, separation, extraction optimization, and bioactivity evaluation of acetylcholinesterase inhibitors from Sophora flavescens Aiton. Phytochemical Analysis, 36(1), 52-67. https://doi.org/10.1002/pca.3415
Vancouver
Zhang Y, Zhang Y, Li S, Liu C, Liang J, Nong Y, et al. Quaternity method for integrated screening, separation, extraction optimization, and bioactivity evaluation of acetylcholinesterase inhibitors from Sophora flavescens Aiton. Phytochemical Analysis. 2025;36(1):52-67. doi:10.1002/pca.3415
BibTeX
@article{Zhang2025,
author = {Zhang, Yutong and Zhang, Yuchi and Li, Sainan and Liu, Chunming and Liang, Jiaqi and Nong, Yuyu and Chen, Ming and Sun, Ruijun},
title = {Quaternity method for integrated screening, separation, extraction optimization, and bioactivity evaluation of acetylcholinesterase inhibitors from Sophora flavescens Aiton},
journal = {Phytochemical Analysis},
year = {2025},
volume = {36},
number = {1},
pages = {52--67},
doi = {10.1002/pca.3415}
}
EUVIMED